-
Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea
-
Hyo Song Kim, Chung Mo Nam, Suk-Yong Jang, Sun Kyu Choi, Minkyung Han, Seonmin Kim, Maria Victoria Moneta, Sae Young Lee, Jae Min Cho, Diego Novick, Sun Young Rha
-
Cancer Res Treat. 2019;51(4):1380-1391. Published online February 18, 2019
-
DOI: https://doi.org/10.4143/crt.2018.476
-
-
Abstract
PDFSupplementary MaterialPubReaderePub
- Purpose
A soft tissue sarcoma (STS) is a rare type of cancer, accounting for 1% of adult solid cancers. The aim of the present study is to determine the incidence of localized and advanced STS in Korean patients, their treatment patterns, and the survival of patients by disease status.
Materials and Methods
The STS patient cohort was defined using National Health Insurance Service medical data from 2002 to 2015. Incidence, distribution, anatomical location of tumors, survival rates (Kaplan-Meyer survival function) and treatment patterns were analyzed by applying different algorithms to the STS cohort containing localized and advanced STS cases.
Results
A total of 7,813 patients were diagnosed with STS from 2007 to 2014, 4,307 were localized STS and 3,506 advanced STS cases. The total incidence of STS was 2.49 per 100,000 person- years: 1.37 per 100,000 person-years for localized STS and 1.12 per 100,000 person-years for advanced STS. The 5-year survival rate after diagnosis was 56.4% for all STS, 82.4% for localized, and 27.2% for advanced STS. Half of the advanced STS patients (49.98%) received anthracycline-containing chemotherapy as initial treatment after diagnosis.
Conclusion
This study provides insights into localized and advanced STS epidemiology, treatment patterns and outcomes in Korea, which could be used as fundamental data in improving clinical outcomes of STS patients in the future.
-
Citations
Citations to this article as recorded by
- Factors predictive of second‐line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database
Takao Mochizuki, Masachika Ikegami, Toru Akiyama Cancer Science.2024; 115(2): 575. CrossRef - Comparative Evaluation of Second-Line Chemotherapy Agents for Advanced Soft Tissue Sarcoma: Gemcitabine/Docetaxel, Pazopanib, and Alternatives
Tae Hun Kim, Ki Hyuk Sung, So Hak Chung Journal of the Korean Orthopaedic Association.2024; 59(1): 22. CrossRef - Secondary hematological malignancies in patients with sarcoma: A single‑center retrospective study
Yoon Jang, Hong Jeong, Chang-Bae Kong, Won Song, Wan Cho, Dae Jeon, Heyjin Kim, Sung Yang, Im Na, Hyo-Rak Lee, Hye Kang Oncology Letters.2024;[Epub] CrossRef - Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas
Qiuzhong Long, Zhengtian Li, Wenkang Yang, Ke Huang, Gang Du Journal of Cancer Research and Clinical Oncology.2024;[Epub] CrossRef - First-Line Anlotinib Treatment for Soft-Tissue Sarcoma in Chemotherapy-Ineligible Patients: An Open-Label, Single-Arm, Phase 2 Clinical Trial
Tao Li, Ying Dong, Yongzhong Wei, Shoufeng Wang, Yunxia Liu, Jia Chen, Wenhua Xiong, Nong Lin, Xin Huang, Meng Liu, Xiaobo Yan, Zhaoming Ye, Binghao Li Clinical Cancer Research.2024; 30(19): 4310. CrossRef - Mortality patterns of soft-tissue sarcomas worldwide up to 2018, with predictions for 2025
Margherita Pizzato, Giulia Collatuzzo, Claudia Santucci, Matteo Malvezzi, Paolo Boffetta, Alessandro Comandone, Fabio Levi, Carlo La Vecchia, Paola Bertuccio, Eva Negri European Journal of Cancer Prevention.2023; 32(1): 71. CrossRef - Chemotherapeutic drugs for soft tissue sarcomas: a review
Zhichao Tian, Weitao Yao Frontiers in Pharmacology.2023;[Epub] CrossRef - Identification of m5C-related molecular subtypes and prediction models in the prognosis and tumor microenvironment infiltration of soft tissue sarcoma
Xianfeng Wang, Yicheng Mao, Hanlu Xu, Jiyang Chen, Xiao chen Heliyon.2023; 9(9): e19680. CrossRef - Incidence, Treatment and Outcome of Patients with Retroperitoneal Soft‐Tissue Sarcoma in Switzerland 2005–2015: A Population‐Based Analysis
Johanna C. F. Willburger, Marco von Strauss, Caspar J. Peterson, Tracy R. Glass, Christoph Kettelhack World Journal of Surgery.2022; 46(2): 461. CrossRef - A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas
Binfeng Liu, Zhongyue Liu, Chengyao Feng, Chao Tu Frontiers in Genetics.2022;[Epub] CrossRef - A novel inflammatory signature for evaluating immune microenvironment status in soft tissue sarcoma
Zhehong Li, Honghong Zheng, Lirui Liu, Zhen Fen, Haiying Cao, Jilong Yang, Junqiang Wei Frontiers in Oncology.2022;[Epub] CrossRef - Issues of diagnostic search of soft tissue sarcoma
A. N. Sergeev, D. A. Maksimov, A. M. Morozov, M. A. Belyak, E. V. Penyaz', M. O. Popova Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2022;[Epub] CrossRef - Issues of diagnostic search of soft tissue sarcoma
A. N. Sergeev, D. A. Maksimov, A. M. Morozov, M. A. Belyak, E. V. Penyaz', M. O. Popova Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2022; 12(6): 15. CrossRef - Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma
Rui Shen, Bo Liu, Xuesen Li, Tengbo Yu, Kuishuai Xu, Jinfeng Ma BMC Cancer.2021;[Epub] CrossRef - Identification of Novel Prognostic Risk Signatures of Soft Tissue Sarcoma Based on Ferroptosis-Related Genes
Wenjing Huang, Yuhe Duan, Xiuwei Yang, Cong Shang, Xin Chen, Huanyu Zhang, Fujiang Li Frontiers in Oncology.2021;[Epub] CrossRef - Pulmonary metastasectomy in bone and soft tissue sarcoma with metastasis to the lung
Charles A Gusho, Christopher W Seder, Nicolas Lopez-Hisijos, Alan T Blank, Marta Batus Interactive CardioVascular and Thoracic Surgery.2021; 33(6): 879. CrossRef - Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs
Li Zhang, Xianzhe Tang, Jia Wan, Xianghong Zhang, Tao Zheng, Zhengjun Lin, Tang Liu Frontiers in Molecular Biosciences.2021;[Epub] CrossRef - Identification and Validation of Pyroptosis-Related lncRNA Signature and Its Correlation with Immune Landscape in Soft Tissue Sarcomas
Zhengjun Lin, Yiting Xu, Xianghong Zhang, Jia Wan, Tao Zheng, Hongxuan Chen, Shijie Chen, Tang Liu International Journal of General Medicine.2021; Volume 14: 8263. CrossRef - Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea—A Sarcoma-Specific, Institutional Registry-Based Analysis
Hyehyun Jeong, Hyeon-Su Im, Wanlim Kim, Jong-Seok Lee, Si Yeol Song, Joon Seon Song, Kyung-Ja Cho, Hye Won Chung, Min Hee Lee, Jeong Eun Kim, Jin-Hee Ahn Cancer Management and Research.2021; Volume 13: 8795. CrossRef - Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma
Zhengjun Lin, Ke Pang, Hongli Li, Xianghong Zhang, Jia Wan, Tao Zheng, Tang Liu, Weijun Peng Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef - Real-World Outcomes of Pazopanib Treatment in Korean Patients with Advanced Soft Tissue Sarcoma: A Multicenter Retrospective Cohort Study
Chung Ryul Oh, Jung Yong Hong, Jee Hung Kim, Ji Sung Lee, Hyo Song Kim, Tae Won Kim, Jin-Hee Ahn, Jeong Eun Kim Targeted Oncology.2020; 15(4): 485. CrossRef - Comprehensive profiling of immune-related genes in soft tissue sarcoma patients
Chuan Hu, Bo Chen, Zhangheng Huang, Chuan Liu, Lin Ye, Cailin Wang, Yuexin Tong, Jiaxin Yang, Chengliang Zhao Journal of Translational Medicine.2020;[Epub] CrossRef
-
10,911
View
-
239
Download
-
20
Web of Science
-
22
Crossref
|